Validation of a method for the quantificaton of bupropion hydroxylation by cytochrome P4502B6 (CYP2B6) in human liver microsomes

被引：0
|
作者：
Lieu, C [1 ]
Simpson, H [1 ]
Van Horn, R [1 ]
Brian, W [1 ]
机构：
[1] Sanofi Synthelabo Res Div, Malvern, PA 19355 USA
来源：
DRUG METABOLISM REVIEWS | 2004年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
99
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [1] Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes
    Coles, Rebeeka
    Kharasch, Evan D.
    PHARMACEUTICAL RESEARCH, 2008, 25 (06) : 1405 - 1411
  • [2] Stereoselective Metabolism of Bupropion by Cytochrome P4502B6 (CYP2B6) and Human Liver Microsomes
    Rebecka Coles
    Evan D. Kharasch
    Pharmaceutical Research, 2008, 25 : 1405 - 1411
  • [3] Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity
    Kharasch, Evan D.
    Mitchell, Darain
    Coles, Rebecka
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (04): : 464 - 474
  • [4] Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P4502B6 in human liver microsomes
    Hesse, LM
    He, P
    Krishnaswamy, S
    Hao, Q
    Hogan, K
    von Moltke, LL
    Greenblatt, DJ
    Court, MH
    PHARMACOGENETICS, 2004, 14 (04): : 225 - 238
  • [5] Validation of bupropion hydroxylation as a selective marker of human cytochrome P4502B6 catalytic activity
    Faucette, SR
    Hawke, RL
    Lecluyse, EL
    Shord, SS
    Yan, BF
    Laethem, RM
    Lindley, CM
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (10) : 1222 - 1230
  • [6] Effect of clopidogrel and ticlopidine on cytochrome P4502B6 activity as measured by bupropion hydroxylation
    Turpeinen, M
    Tolonen, A
    Uusitalo, J
    Jalonen, J
    Pelkonen, O
    Laine, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (06) : 553 - 559
  • [7] Inactivation of the cytochrome P4502B6 (CYP2B6) by tamoxifen and N-desmethyltamoxifen in vitro.
    Desta, Z
    Park, J
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P68 - P68
  • [8] Cytochrome P4502B6 activity as measured by bupropion hydroxylation: Effect of induction by rifampin and ethnicity
    Loboz, Katarzyna K.
    Gross, Annette S.
    Williams, Kenneth M.
    Liauw, Winston S.
    Day, Richard O.
    Blievernicht, Julia K.
    Zanger, Ulrich M.
    McLachlan, Andrew J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (01) : 75 - 84
  • [9] Validation of bupropion (B) hydroxylation as a CYP2B6 (2B6) catalytic marker.
    Lindley, C
    Faucette, S
    LeCluyse, E
    Shifflet, S
    Yan, B
    Hawke, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 119 - 119
  • [10] Involvement of human liver cytochrome P4502B6 in the metabolism of propofol
    Oda, Y
    Hamaoka, N
    Hiroi, T
    Imaoka, S
    Hase, I
    Tanaka, K
    Funae, Y
    Ishizaki, T
    Asada, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (03) : 281 - 285
12345